Gio Talk - Overcome the Challenge of EGFR M+ NSCLC management

eLearning on BoehringerOne

Visit BoehringerOne.com

Giotalk Advanced	Duration
Session 1 Multiplex screening to detect uncommon and compound EGFR mutations	09:00
Session 2 The latest in osimertinib-resistant NSCLC treatment	04:00
Session 3 State-of-the-art in EGFR mutant NSCLC	05:00
Session 4 Clinical updates in exon 20 ins and other EGFR TKI-resistant NSCLC	07:00
Session 5 Latest updates in 1st-/2nd-line NSCLC therapy	06:00
Session 6 The EGFR TKI-based Combination Strategy	12:00

Giotalk_Module 2: Overcome the Challenge of EGFR M+ NSCLC management